Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | NOS2 | P35228 | 2/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.31 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.31 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | THPO | P40225 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CETP | P11597 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20388820 | 1.00 | CYP1A2 (0.37) | CYP1A2MEN1KMT2ASMN1; SMN2ALOX15 | |
| SCHEMBL20388834 | 0.89 | ANPEP (0.32) | CYP1A2MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL22400069 | 0.81 | MEN1 (0.43) | CYP1A2MEN1KMT2ASMN1; SMN2ALOX15 | |
| SCHEMBL21011320 | 0.81 | MEN1 (0.43) | CYP1A2MEN1KMT2ASMN1; SMN2ALOX15 | |
| SCHEMBL17985760 | 0.81 | MEN1 (0.41) | CYP1A2MEN1KMT2ASMN1; SMN2ALOX15 | |
| SCHEMBL4883177 | 0.81 | MEN1 (0.41) | CYP1A2MEN1KMT2ASMN1; SMN2ALOX15 | |
| SCHEMBL12664131 | 0.79 | MEN1 (0.40) | CYP1A2MEN1KMT2ASMN1; SMN2ALOX15 | |
| SCHEMBL7158448 | 0.79 | MEN1 (0.40) | CYP1A2MEN1KMT2ASMN1; SMN2ALOX15 | |
| SCHEMBL171399 | 0.79 | MEN1 (0.40) | CYP1A2MEN1KMT2ASMN1; SMN2ALOX15 | |
| SCHEMBL18822222 | 0.79 | MEN1 (0.40) | CYP1A2MEN1KMT2ASMN1; SMN2ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200061192-A1 | DERIVATIZED POLYGLUCOSAMINES FOR DELIVERY OF SMALL MOLECULES, PEPTIDES, AND PROTEINS | SYNEDGEN INC (US) | 2020-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200061192-A1 | DERIVATIZED POLYGLUCOSAMINES FOR DELIVERY OF SMALL MOLECULES, PEPTIDES, AND PROTEINS | MUC1, DDOST, EPCAM | CYP1A2 4879/4885MEN1 1199/4885KMT2A 3524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.